• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, June 29, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

ORNL launches rapid access licensing program to speed up COVID-19 solutions

Bioengineer by Bioengineer
June 19, 2020
in Science News
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Oak Ridge National Laboratory, U.S. Dept. of Energy

The Department of Energy’s Oak Ridge National Laboratory has launched a program designed to accelerate deployment of innovations that may help fight the COVID-19 pandemic. The COVID-19 Rapid Access Licensing Program will allow companies to license these select technologies at no cost for one year.

“As ORNL races to find solutions to the COVID-19 pandemic, the Technology Transfer Office is working to provide streamlined processes and easy access to intellectual property so that companies can work with ORNL to quickly address this public health crisis,” said Jennifer Caldwell, ORNL’s group leader for technology commercialization.

In collaboration with researchers, ORNL’s Technology Transfer Office is creating a growing portfolio of inventions available to license through the program. The licenses are nonexclusive, meaning more than one person can hold the right to use the technology. Interested licensees must demonstrate intent to use ORNL’s innovations to address COVID-19 and commit to disseminating resulting products as widely and quickly as possible. Only U.S. entities, companies and universities are eligible.

Alternative licenses will be available for companies creating products that require exclusivity to support large development investments, such as for diagnostic platforms, drug delivery systems, therapies and vaccines.

ORNL has quickly responded to the COVID-19 pandemic through its research efforts in computational science, advanced manufacturing, data science and neutron science. Inventions available to license through this program represent ORNL strengths in these areas as well as in areas ranging from biological sciences to spectrometry to next-generation materials.

“ORNL has shown leadership in adapting our research, operations and community engagement efforts to combat COVID-19 and mitigate its effects on our community,” said ORNL Director Thomas Zacharia. “We are pleased to now offer industry partners a quicker and easier way to use our strong technology portfolio for COVID-19 solutions.”

###

ORNL joins DOE national laboratories across the nation in the fight against COVID-19. Additional information on DOE technologies, facilities, experts and resources accessible to partners working against the virus is available through the recently announced Lab Partnering Service COVID-19 Portal.

UT-Battelle manages ORNL for DOE’s Office of Science. The single largest supporter of basic research in the physical sciences in the United States, the Office of Science is working to address some of the most pressing challenges of our time. For more information, please visit https://www.energy.gov/science/.

Media Contact
Abby Bower
[email protected]

Original Source

https://www.ornl.gov/news/ornl-launches-rapid-access-licensing-program-speed-covid-19-solutions

Tags: Research/DevelopmentTechnology TransferTechnology/Engineering/Computer Science
Share12Tweet8Share2ShareShareShare2

Related Posts

Tracking Lanthanide-Labeled Microplastics in Plants

June 25, 2026

POSTECH Researchers Slash Cost of Reconstituted Cell-Free Systems by 95%

June 25, 2026

AI and Physics Collaborate to Design Advanced Hydrogen Storage Materials

June 25, 2026

Natural Hallucinogens: Evolution’s Ecological Tools, Not Mere Chemical Byproducts

June 25, 2026
Please login to join discussion

POPULAR NEWS

  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates

    92 shares
    Share 36 Tweet 23
  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tracking Lanthanide-Labeled Microplastics in Plants

POSTECH Researchers Slash Cost of Reconstituted Cell-Free Systems by 95%

AI and Physics Collaborate to Design Advanced Hydrogen Storage Materials

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.